BIO

Director, Office of Policy, Center for Drug Evaluation and Research (CDER)

FDA

Ashley Boam is Director of the Office of Policy for Pharmaceutical Quality (OPPQ) in OPQ at CDER. She oversees the development and communication of science- and risk-based drug quality policies and standards, including application assessment and inspection. OPPQ coordinates OPQ's international quality efforts, leads CDER's compendial operations, participates in quality standard-setting organizations, and addresses policy issues related to drug-device combination products. Ashley holds an MSBE from the University of Alabama at Birmingham and a BSE from Tulane University, both in Biomedical Engineering.